From the Floor of HIMSS 2017 (Orlando, FL) – February 20, 2017 – CareSkore, the leader in
end-to-end personalized population health management, announced today the release of
version 3.0 of its population health platform. This release incorporates an extensive list of
major new features, including incorporating social determinants in risk stratification plus
significant expansion of AI-enhanced patient engagement, such as support for Amazon
(NASDAQ: AMZN) Polly, the technology behind Alexa. CareSkore also announced
comprehensive CCM updates around 2017 CMS changes and the availability of free custom
reports on performance by provider. In earlier releases, CareSkore announced the industry’s
first population health management as a serviceTM and strong business results for 2016 and
expectations for 2017.
“With 3.0, CareSkore sets a new standard for leveraging advanced technologies to deliver
unrivaled population health management,” said Jas Grewal, CEO of CareSkore. “And our
unmatched incorporation of all 2017 billing changes for CCM rewrite the economics for
providers to include this service with greater benefit. We are tightly tied into the market and
continuously supporting better ways to meet the needs of both providers and payers as they
transition to value-based care.”
CareSkore’s SaaS personalized population health management platform incorporates advanced
real-time analytics and innovative automated patient engagement to deliver optimized quality
of care and revenue. With v3.0, CareSkore’s machine learning analytics engine, Zeus, now
provides cohort analysis against a global database of 43M patients to measure individual
patient risk factors. Providers can benchmark each patient’s clinical risks against this database
around factors they select (e.g., age, income, sex).
In addition, version 3.0 also brings significant improvements to CareSkore’s AI-enhanced
patient engagement technology, Iris. Incorporating real-time updates on patient metrics, Iris
now supports more devices for engagement, including Amazon Polly. Coupled with broadened
communication channels, such as video chat (desktop or mobile) and built-in patient calling
from a computer or mobile phone, Iris delivers a greater set of options for engaging patients.
These additions further extend Iris’ technology and market leadership, adding to its support of
telephone, email, text, IVR, wearables, telehealth, and in-app chat.
“CareSkore newly enhanced offering is a significant enabler of comprehensive population
health,” said Dr. Pam Khosla, Chief, Division of Hematology and Oncology, Mt. Sinai Hospital.
“This platform continues to change the game for optimizing clinical and financial outcomes
around value-based care.”
CareSkore is also updating its CCM platform to reflect the new billing codes and requirements
for 2017 from CMS. These 2017 policy changes significantly raised incentives and lowered
barriers to provide and bill for CCM. CareSkore dramatically simplifies aligning with CCM
changes to optimize outcomes and revenue. In addition, CareSkore’s CCM calculator provides
guidance on CCM revenue that a provider can expect based on their population characteristics.
https://www.careskore.com/chronic-care-management
In addition, CareSkore is now offering custom performance reports by US provider. These free,
no-obligation reports give insights into the clinical and financial health of each organization.
https://www.careskore.com/hospital-search
About CareSkore
CareSkore is the leading provider of personalized population health management, leveraging
machine-learning to generate real-time predictive and prescriptive analytics to understand each
patient you are managing, what you are managing them for, and how you are/should be
managing them. CareSkore’s AI-enhanced post-discharged engagement reduces risk of patient
behaviors that could lead to poorer outcomes. CareSkore’s end-to-end patient care
management platform ensures quality results and maximum revenue with value-based
contracts.
For additional information, please contact Natacha Rousseau at 323-352-6417 or by email at
[email protected]